Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-25

Clinical Trial Update: Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRD [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update describes a Chinese medicine Yi-Qi-Qing-Jie Herbal Compound combined with immunosuppressants being studied in IgA nephropathy patients at …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Immunosuppression therapy (immunosuppressive therapy)
  • Yi-Qi-Qing-Jie Herbal Compound (Yi-Qi-Qing-Jie Herbal Compound)

Snippet

Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Conditions: IgA Nephropathy at High Risk of Developing ESRD | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING